{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:01:23Z","timestamp":1791820883078,"version":"4.3.4"},"reference-count":190,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cgh.2020.04.069","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T13:17:12Z","timestamp":1588252632000},"page":"1759-1779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Drug-Induced Colitis"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2721-4995","authenticated-orcid":false,"given":"Shadi","family":"Hamdeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Micic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hanauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2020.04.069_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000199740","article-title":"Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem","volume":"41","author":"Tanner","year":"1988","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2020.04.069_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/bega.2001.0231","article-title":"Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine","volume":"15","author":"Smale","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib3","first-page":"878","article-title":"Drug-induced colitis: a review","volume":"79","author":"Fortson","year":"1984","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1572-0241.2004.30192.x","article-title":"Colonic toxicity of administered drugs and chemicals","volume":"99","author":"Cappell","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib5","first-page":"1684","article-title":"Colonic toxicity of administered medications and chemicals","volume":"88","author":"Cappell","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cgh.2013.09.066","article-title":"The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study","volume":"12","author":"Gentile","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dld.2014.09.019","article-title":"Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012","volume":"47","author":"Verhaegh","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00365521.2014.940378","article-title":"The epidemiology of microscopic colitis: a 10-year pathology-based nationwide Danish cohort study","volume":"50","author":"Bonderup","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib9","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1097\/MIB.0000000000000520","article-title":"Ethnic distribution of microscopic colitis in the United States","volume":"21","author":"Turner","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2016.477","article-title":"Diagnosis and management of microscopic colitis","volume":"112","author":"Pardi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ajg.2015.119","article-title":"Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs","volume":"110","author":"Masclee","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/apt.13583","article-title":"High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors","volume":"43","author":"Verhaegh","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.069_bib13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/MIB.0000000000000143","article-title":"Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases","volume":"20","author":"Bonderup","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s10620-016-4306-z","article-title":"Incidence, clinical presentation, and associated factors of microscopic colitis in Northern France: a population-based study","volume":"62","author":"Fumery","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.04.069_bib15","first-page":"2908","article-title":"Lansoprazole-associated microscopic colitis: a case series","volume":"97","author":"Thomson","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gut.33.5.683","article-title":"Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study","volume":"33","author":"Riddell","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.069_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1572-0241.2006.00902.x","article-title":"Drug consumption and the risk of microscopic colitis","volume":"102","author":"Fernandez-Banares","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/gut.45.3.375","article-title":"Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis","volume":"45","author":"Baert","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.069_bib19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0140-6736(00)02797-5","article-title":"Acarbose and lymphocytic colitis","volume":"356","author":"Piche","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2020.04.069_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gcb.2009.09.005","article-title":"[Acute lymphocytic colitis due to carbamazepine]","volume":"34","author":"Maroy","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2020.04.069_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/jcp.0b013e31815a257f","article-title":"Clozapine-induced microscopic colitis: a case report and review of the literature","volume":"27","author":"Pelizza","year":"2007","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.cgh.2020.04.069_bib22","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1055\/s-0028-1082795","article-title":"[Persistent diarrhea and loss of weight during therapy with leflunomide]","volume":"133","author":"Gugenberger","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.cgh.2020.04.069_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/CMR.0000000000000252","article-title":"Anti-PD1-induced collagenous colitis in a melanoma patient","volume":"26","author":"Baroudjian","year":"2016","journal-title":"Melanoma Res"},{"key":"10.1016\/j.cgh.2020.04.069_bib24","first-page":"1101","article-title":"[Chronic diarrhea and lymphocytic colitis associated with Daflon therapy]","volume":"23","author":"Mennecier","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2020.04.069_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.35.3.426","article-title":"Drug induced lymphocytic colitis","volume":"35","author":"Beaugerie","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.069_bib26","first-page":"83","article-title":"[Chronic diarrhea following ingestion of Tardyferon associated with lymphocytic colitis]","volume":"21","author":"Bouchet-Laneuw","year":"1997","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2020.04.069_bib27","first-page":"362","article-title":"[Lymphocytic colitis likely attributable to use of vinburnine (Cervoxan)]","volume":"22","author":"Chauveau","year":"1998","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2020.04.069_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.mayocp.2016.02.006","article-title":"Colon ischemia: an update for clinicians","volume":"91","author":"Cotter","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2020.04.069_bib29","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s10620-008-0579-1","article-title":"Endoscopic findings and clinicopathologic characteristics of ischemic colitis: a report of 85 cases","volume":"54","author":"Zou","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.04.069_bib30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1572-0241.2004.21436.x","article-title":"Risk factors for colon ischemia","volume":"99","author":"Walker","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cgh.2009.09.006","article-title":"Diseases and drugs that increase risk of acute large bowel ischemia","volume":"8","author":"Longstreth","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cgh.2007.12.015","article-title":"Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Andresen","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib33","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s10620-016-4162-x","article-title":"Ischemic colitis as a complication of medication use: an analysis of the Federal Adverse Event Reporting System","volume":"61","author":"Bielefeldt","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.04.069_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40264-013-0041-y","article-title":"Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-alpha inhibitors: an analysis of reports to the US FDA Adverse Event Reporting System","volume":"36","author":"Salk","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2020.04.069_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1345\/aph.1R526","article-title":"Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature","volume":"47","author":"Salk","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2020.04.069_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2169\/internalmedicine.35.583","article-title":"Development of ischemic colitis and scleroderma renal crisis following methylprednisolone pulse therapy for progressive systemic sclerosis","volume":"35","author":"Yamanishi","year":"1996","journal-title":"Intern Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib37","doi-asserted-by":"crossref","DOI":"10.5301\/tj.5000392","article-title":"Ischemic colitis diagnosed by magnetic resonance imaging during lenalidomide treatment in a patient with relapsed multiple myeloma","volume":"102","author":"Guerrini","year":"2016","journal-title":"Tumori"},{"key":"10.1016\/j.cgh.2020.04.069_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/gyno.1997.4842","article-title":"A\u00a0retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer","volume":"67","author":"Seewaldt","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cgh.2020.04.069_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/jjco\/hyv038","article-title":"Severe ischemic colitis after treatment of bile-duct cancer using gemcitabine and cisplatin","volume":"45","author":"Osumi","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cgh.2020.04.069_bib40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/clon.2003.0216","article-title":"Vinorelbine and ischaemic colitis","volume":"15","author":"Olithselvan","year":"2003","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.cgh.2020.04.069_bib41","first-page":"667","article-title":"[Ischemic colitis induced by cocaine. Clinical case]","volume":"130","author":"Boza","year":"2002","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.cgh.2020.04.069_bib42","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.gie.2012.02.016","article-title":"High mortality of cocaine-related ischemic colitis: a hybrid cohort\/case-control study","volume":"75","author":"Elramah","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2020.04.069_bib43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archsurg.2009.139","article-title":"Methamphetamine colitis: a rare case of ischemic colitis in a young patient","volume":"144","author":"Holubar","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/j.cgh.2020.04.069_bib44","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.3748\/wjg.v16.i36.4564","article-title":"Risk factors associated with the development of ischemic colitis","volume":"16","author":"Cubiella Fernandez","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib45","first-page":"95","article-title":"[Digitalis poisoning with severe ischemic colitis: a favorable course after treatment with specific antibodies]","volume":"14","author":"Bourhis","year":"1990","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2020.04.069_bib46","first-page":"830","article-title":"[Ischemic colitis following digitalis poisoning]","volume":"55","author":"Keller","year":"1984","journal-title":"Chirurg"},{"key":"10.1016\/j.cgh.2020.04.069_bib47","first-page":"553","article-title":"Diltiazem counteracts digitalis-dependent splanchnic vasoconstriction in man","volume":"25","author":"Gasic","year":"1987","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.cgh.2020.04.069_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5946\/ce.2011.44.2.129","article-title":"A\u00a0case of oral-contraceptive related ischemic colitis in young woman","volume":"44","author":"Seon","year":"2011","journal-title":"Clin Endosc"},{"key":"10.1016\/j.cgh.2020.04.069_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000048851","article-title":"Ischemic colitis during pregnancy and contraceptive medication","volume":"64","author":"Frossard","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2020.04.069_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cgh.2014.07.061","article-title":"A\u00a0population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis","volume":"13","author":"Yadav","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2982.2007.01015.x","article-title":"Assessment of potential risk factors associated with ischaemic colitis","volume":"20","author":"Chang","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2020.04.069_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09513590802002163","article-title":"Ischemic colitis in postmenopausal women taking hormone replacement therapy","volume":"24","author":"Zervoudis","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cgh.2020.04.069_bib53","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/j.1572-0241.2007.01260.x","article-title":"Pharmacologically mediated colon ischemia","volume":"102","author":"Hass","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MAJ.0b013e31818dd715","article-title":"Colonic necrosis due to oral kayexalate in a critically-ill patient","volume":"337","author":"Thomas","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cgh.2020.04.069_bib55","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3182999d8d","article-title":"Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury","volume":"37","author":"Swanson","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2020.04.069_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40264-013-0134-7","article-title":"Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS","volume":"37","author":"Nguyen","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2020.04.069_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207912","article-title":"Colitis possibly induced by quetiapine","volume":"2015","author":"de Beaurepaire","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cgh.2020.04.069_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ebiom.2016.02.020","article-title":"Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study","volume":"5","author":"Every-Palmer","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cgh.2020.04.069_bib59","first-page":"213","article-title":"Colon ischemia after weight-loss medication in a 36-year-old woman","volume":"80","author":"Sharma","year":"2016","journal-title":"Conn Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib60","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1155\/2003\/167127","article-title":"Ischemic colitis after weight-loss medication","volume":"17","author":"Comay","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib61","first-page":"309","article-title":"Ischemic colitis associated with herbal product use in a young woman","volume":"15","author":"Ryan","year":"2002","journal-title":"J\u00a0Am Board Fam Pract"},{"key":"10.1016\/j.cgh.2020.04.069_bib62","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3349\/ymj.2008.49.3.496","article-title":"A\u00a0case of ischemic colitis associated with the herbal food supplement ma huang","volume":"49","author":"Song","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.cgh.2020.04.069_bib63","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4065\/81.12.1630","article-title":"Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement","volume":"81","author":"Sultan","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2020.04.069_bib64","first-page":"276","article-title":"Pseudoephedrine-induced ischemic colitis: case report and literature review","volume":"15","author":"Sherid","year":"2014","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2011.5270","article-title":"Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman","volume":"2012","author":"Tan","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cgh.2020.04.069_bib66","doi-asserted-by":"crossref","first-page":"748","DOI":"10.5858\/arpa.2015-0451-RA","article-title":"The ever-changing landscape of drug-induced injury of the lower gastrointestinal tract","volume":"140","author":"Marginean","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharma.2012.12.003","article-title":"[Meloxicam-induced colitis revealed by acute abdominal pain]","volume":"71","author":"Seddik","year":"2013","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.cgh.2020.04.069_bib68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00004836-199707000-00017","article-title":"Acute colitis associated with etodolac","volume":"25","author":"Wilcox","year":"1997","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4321\/S1130-01082013000200016","article-title":"Severe colitis due to indomethacin suppository","volume":"105","author":"Tas","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.cgh.2020.04.069_bib70","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2036.2003.01519.x","article-title":"Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study","volume":"17","author":"Gleeson","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.069_bib71","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1463-1318.2009.01948.x","article-title":"Colonic mucosal lesions associated with long-term or short-term administration of nonsteroidal anti-inflammatory drugs","volume":"12","author":"Shibuya","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-3565(05)00980-8","article-title":"Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease","volume":"4","author":"Takeuchi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib73","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-156-5-201203060-00007","article-title":"Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study","volume":"156","author":"Ananthakrishnan","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib74","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365521.2014.966753","article-title":"Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease","volume":"50","author":"Kvasnovsky","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib76","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/ph3041084","article-title":"Non steroidal anti-inflammatory drugs and inflammatory bowel disease","volume":"3","author":"Klein","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cgh.2020.04.069_bib77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","article-title":"Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease","volume":"50","author":"Long","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib78","first-page":"142","article-title":"Rofecoxib and inflammatory bowel disease: clinical and pathologic observations","volume":"39","author":"Wilcox","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib79","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1111\/j.1572-0241.2002.07142.x","article-title":"Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib","volume":"97","author":"Gornet","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib80","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","article-title":"Paradoxical inflammation induced by anti-TNF agents in patients with IBD","volume":"9","author":"Cleynen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jbspin.2011.10.001","article-title":"Development of inflammatory bowel disease during anti-TNF-alpha therapy for inflammatory rheumatic disease: a nationwide series","volume":"79","author":"Toussirot","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cgh.2020.04.069_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MAJ.0b013e3180312362","article-title":"Tumor necrosis factor-alpha inhibitor associated ulcerative colitis","volume":"333","author":"Prescott","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cgh.2020.04.069_bib83","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00384-011-1250-4","article-title":"Pancolitis during etanercept treatment of rheumatoid arthritis relapsing on the administration of further two TNF-alpha inhibitors","volume":"27","author":"Actis","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/apt.15370","article-title":"Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFalpha agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease","volume":"50","author":"Korzenik","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.069_bib85","first-page":"2812980","article-title":"Henoch-Schonlein purpura with adalimumab therapy for ulcerative colitis: a case report and review of the literature","volume":"2016","author":"LaConti","year":"2016","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib86","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ecco-jcc\/jjz164","article-title":"Severe attack of Henoch-Schonlein purpura with neurologic involvement during adalimumab treatment for Crohn's disease","volume":"14","author":"Condamina","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2020.04.069_bib87","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3109\/00365521.2014.946087","article-title":"Two cases of ulcerative colitis developing in rheumatoid arthritis patients during abatacept therapy","volume":"49","author":"Motohashi","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11894-017-0540-6","article-title":"Gastrointestinal and hepatic complications of immune checkpoint inhibitors","volume":"19","author":"Cramer","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2020.04.069_bib89","doi-asserted-by":"crossref","first-page":"56619","DOI":"10.18632\/oncotarget.10651","article-title":"Fatal gastrointestinal toxicity with ipilimumab after BRAF\/MEK inhibitor combination in a melanoma patient achieving pathological complete response","volume":"7","author":"Gonzalez-Cao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cgh.2020.04.069_bib90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib91","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4","volume":"24","author":"Beck","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2020.04.069_bib92","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/CMR.0000000000000165","article-title":"Ipilimumab-induced colitis in patients with metastatic melanoma","volume":"25","author":"De Felice","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.cgh.2020.04.069_bib93","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ecco-jcc\/jjv227","article-title":"Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease","volume":"10","author":"Marthey","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2020.04.069_bib94","first-page":"11","article-title":"Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma","volume":"10","author":"Berman","year":"2010","journal-title":"Cancer Immun"},{"key":"10.1016\/j.cgh.2020.04.069_bib95","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41591-018-0238-9","article-title":"Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib96","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344805","article-title":"Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: a systematic review and meta-analysis","volume":"6","author":"Wang","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cgh.2020.04.069_bib97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ctrv.2016.02.003","article-title":"Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy","volume":"45","author":"Eigentler","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cgh.2020.04.069_bib98","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib99","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","article-title":"Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study","volume":"110","author":"Ottmann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2020.04.069_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000448983","article-title":"Dasatinib-induced T-cell-mediated colitis: a case report and review of the literature","volume":"136","author":"Shanshal","year":"2016","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cgh.2020.04.069_bib101","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/annonc\/mdn566","article-title":"Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenib","volume":"19","author":"Loriot","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cgh.2020.04.069_bib102","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10637-015-0279-6","article-title":"Ulcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumab","volume":"33","author":"Tanaka","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.cgh.2020.04.069_bib103","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(09)70112-3","article-title":"Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis","volume":"10","author":"Hapani","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cgh.2020.04.069_bib104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.critrevonc.2013.10.002","article-title":"Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis","volume":"89","author":"Qi","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cgh.2020.04.069_bib105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12029-015-9752-x","article-title":"Bowel perforation after treatment with sorafenib: a case report and review of literature","volume":"47","author":"Hamdeh","year":"2016","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.cgh.2020.04.069_bib106","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0016-5107(99)70171-9","article-title":"Irinotecan (CPT-11) induced colitis: report of a case and review of Food and Drug Administration MEDWATCH reporting","volume":"50","author":"Sears","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2020.04.069_bib107","first-page":"59","article-title":"[5-Fluorouracil-induced colitis--a review based upon consideration of 6 cases]","volume":"40","author":"Madisch","year":"2002","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib108","first-page":"619","article-title":"[Anticancer drug-induced colitis--case report and review of the literature]","volume":"24","author":"Abe","year":"1997","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.cgh.2020.04.069_bib109","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.prp.2014.05.005","article-title":"Capecitabine induced colitis","volume":"210","author":"Maggo","year":"2014","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cgh.2020.04.069_bib110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00384-005-0753-2","article-title":"Capecitabine-induced pancolitis","volume":"22","author":"Alexandrescu","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib111","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/cncr.20546","article-title":"Colitis in patients with breast carcinoma treated with taxane-based chemotherapy","volume":"101","author":"Li","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2020.04.069_bib112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejrad.2007.04.024","article-title":"Radiologic findings in taxane induced colitis","volume":"66","author":"Kaur","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cgh.2020.04.069_bib113","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/gyno.1995.1140","article-title":"Intestinal perforation secondary to paclitaxel","volume":"57","author":"Rose","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cgh.2020.04.069_bib114","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.gastrohep.2010.05.009","article-title":"Rectal bleeding and diarrhea caused by bortezomib-induced colitis","volume":"33","author":"Nogales Rincon","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib115","first-page":"325","article-title":"Bortezomib-related colon mucositis in a multiple myeloma patient","volume":"17","author":"Siniscalchi","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cgh.2020.04.069_bib116","first-page":"586","article-title":"[Case of drug-induced colitis like ulcerative colitis during IL-2 therapy for multiple bone metastasis after operation of kidney cancer]","volume":"100","author":"Yamanaka","year":"2009","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"10.1016\/j.cgh.2020.04.069_bib117","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1440-1746.2011.06890.x","article-title":"Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and\/or ribavirin","volume":"26","author":"Watanabe","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib118","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.crohns.2010.10.007","article-title":"Rapid onset of ulcerative colitis after treatment with interferon beta1a in a patient with multiple sclerosis","volume":"5","author":"Tuna","year":"2011","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2020.04.069_bib119","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0399-8320(05)80736-5","article-title":"[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C]","volume":"29","author":"Khalil","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2020.04.069_bib120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s15010-016-0915-x","article-title":"Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C","volume":"44","author":"Izzo","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.cgh.2020.04.069_bib121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4292\/wjgpt.v1.i6.132","article-title":"Mesalamine induced symptom exacerbation of ulcerative colitis: case report and brief discussion","volume":"1","author":"Gupta","year":"2010","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.069_bib122","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/0016-5085(95)90154-X","article-title":"Exacerbation of chronic ulcerative colitis with mesalamine","volume":"108","author":"Sturgeon","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.04.069_bib123","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00384-009-0727-x","article-title":"Mesalamine enema-induced exacerbation of ulcerative colitis","volume":"24","author":"Bousseaden","year":"2009","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib124","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/gut.37.6.838","article-title":"Mesalazine induced exacerbation of ulcerative colitis","volume":"37","author":"Kapur","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.069_bib125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM199803263381320","article-title":"Diarrhea associated with mesalamine in a patient with chronic nongranulomatous enterocolitis","volume":"338","author":"Fine","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib126","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.2007.138305","article-title":"Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease","volume":"57","author":"El Fassi","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.069_bib127","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/ibd.20215","article-title":"Exacerbation of ulcerative colitis after rituximab salvage therapy","volume":"13","author":"Goetz","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/00365521.2017.1280530","article-title":"Rituximab-induced Crohn's disease","volume":"52","author":"Varma","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib129","doi-asserted-by":"crossref","first-page":"12963","DOI":"10.3748\/wjg.v21.i45.12963","article-title":"First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy","volume":"21","author":"Atreya","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib130","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10067-011-1827-x","article-title":"Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review","volume":"30","author":"Gout","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib131","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.04.069_bib132","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib133","first-page":"1131","article-title":"Emergence of inflammatory bowel disease during treatment with secukinumab","volume":"12","author":"Fobelo Lozano","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2020.04.069_bib134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/09546634.2017.1329511","article-title":"Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease","volume":"29","author":"Hohenberger","year":"2018","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.cgh.2020.04.069_bib135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaad.2016.10.027","article-title":"Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: a presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials","volume":"76","author":"Reich","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib136","first-page":"238","article-title":"Gold-induced colitis: a case report and review of the literature","volume":"60","author":"Teodorescu","year":"1993","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/ard.46.10.787","article-title":"Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature","volume":"46","author":"Langer","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib138","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2020.04.069_bib139","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.transproceed.2012.11.003","article-title":"Case report: Crohn's-like mycophenolate-induced colitis, a fallout in steroid-free regimens","volume":"45","author":"Jakes","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2020.04.069_bib140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/his.12222","article-title":"Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis","volume":"63","author":"Liapis","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.cgh.2020.04.069_bib141","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1681\/ASN.V131277","article-title":"Gastrointestinal complications of transplant immunosuppression","volume":"13","author":"Helderman","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2020.04.069_bib142","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jclinpath-2012-200888","article-title":"Pointers and pitfalls of mycophenolate-associated colitis","volume":"66","author":"Lee","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cgh.2020.04.069_bib143","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/modpathol.2009.44","article-title":"Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil","volume":"22","author":"Selbst","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cgh.2020.04.069_bib144","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/PAS.0b013e31829ab1ef","article-title":"Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis","volume":"37","author":"Star","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2020.04.069_bib145","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation","volume":"331","author":"Multicenter","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib146","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A\u00a0comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2020.04.069_bib147","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2006.00624.x","article-title":"Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation","volume":"101","author":"Worns","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib148","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1432-2277.2009.01009.x","article-title":"Two cases of severe de novo colitis in kidney transplant recipients after conversion to prolonged-release tacrolimus","volume":"23","author":"Kurnatowska","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2020.04.069_bib149","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2011.44.2.137","article-title":"Rifampin-induced pseudomembranous colitis with rectosigmoid sparing","volume":"44","author":"Yim","year":"2011","journal-title":"Clin Endosc"},{"key":"10.1016\/j.cgh.2020.04.069_bib150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MCG.0b013e31802dfaf7","article-title":"Clinical aspects of rifampicin-associated pseudomembranous colitis","volume":"41","author":"Jung","year":"2007","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib151","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib152","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwr400","article-title":"Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based Finnish case-control study","volume":"175","author":"Virta","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2020.04.069_bib153","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3109\/00365528708991950","article-title":"Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study","volume":"22","author":"Gilat","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib154","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/ajg.2011.304","article-title":"Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis","volume":"106","author":"Shaw","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2036.1997.147323000.x","article-title":"Acyclovir-induced colitis","volume":"11","author":"Wardle","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.04.069_bib156","first-page":"2110","article-title":"Acyclovir-associated colitis","volume":"88","author":"Moshkowitz","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib157","first-page":"1187","article-title":"[Iatrogenic colitis during flucytosine treatment for neuromeningeal cryptococcosis]","volume":"59","author":"Fond","year":"1983","journal-title":"Sem Hop"},{"key":"10.1016\/j.cgh.2020.04.069_bib158","article-title":"Flucytosine-induced colitis","volume":"2014","author":"Sohail","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cgh.2020.04.069_bib159","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/JCP.0b013e31817d8725","article-title":"Response to clozapine-induced microscopic colitis: a case report and review of the literature","volume":"28","author":"Hawe","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.cgh.2020.04.069_bib160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.305.6857.810-a","article-title":"Diarrhoea during treatment with clozapine: association with lymphocyte count","volume":"305","author":"Harvey","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2020.04.069_bib161","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4088\/JCP.v69n0509","article-title":"Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases","volume":"69","author":"Palmer","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.cgh.2020.04.069_bib162","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00004836-199201000-00016","article-title":"Acute colitis associated with prolonged administration of neuroleptics","volume":"14","author":"Larrey","year":"1992","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib163","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1002\/ibd.21736","article-title":"Ulcerative colitis after anesthesia with desflurane and sevoflurane","volume":"17","author":"Yuksel","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib164","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000143156","article-title":"Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone","volume":"77","author":"Charach","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2020.04.069_bib165","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/ajkd.2000.19107","article-title":"Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment","volume":"36","author":"Fervenza","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2020.04.069_bib166","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1016\/j.cgh.2015.02.015","article-title":"Sevelamer-induced colitis presenting as a pseudotumor","volume":"13","author":"Okwara","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib167","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12876-016-0441-4","article-title":"A\u00a0case report of sevelamer-associated recto-sigmoid ulcers","volume":"16","author":"Tieu","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib168","doi-asserted-by":"crossref","first-page":"k872","DOI":"10.1136\/bmj.k872","article-title":"Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study","volume":"360","author":"Abrahami","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2020.04.069_bib169","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/1060028019827852","article-title":"Dipeptidyl peptidase-4 inhibitors and inflammatory bowel disease risk: a meta-analysis","volume":"53","author":"Radel","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2020.04.069_bib170","first-page":"609","article-title":"Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine)","volume":"88","author":"Dahlman","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.cgh.2020.04.069_bib171","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40360-015-0031-z","article-title":"Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature","volume":"16","author":"Boga","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.cgh.2020.04.069_bib172","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s10350-008-9218-3","article-title":"Nicorandil-induced colonic ulceration: a new cause of colonic ulceration. Report of four cases","volume":"51","author":"Titi","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2020.04.069_bib173","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209799","article-title":"When treatment can be worse than the disease: nicorandil-induced colitis","volume":"2015","author":"Samra","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cgh.2020.04.069_bib174","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1308\/003588412X13171221501573","article-title":"Nicorandil associated anal ulcers: an estimate of incidence","volume":"94","author":"Colvin","year":"2012","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.cgh.2020.04.069_bib175","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ajog.2010.12.035","article-title":"Nicorandil-induced rectovaginal fistula","volume":"204","author":"Neely","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cgh.2020.04.069_bib176","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2169\/internalmedicine.31.636","article-title":"Methyldopa-induced colitis in a patient with membranoproliferative glomerulonephritis","volume":"31","author":"Itoh","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.cgh.2020.04.069_bib177","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/MEG.0b013e3282f45740","article-title":"Pravastatin-induced colitis","volume":"20","author":"Mukhopadhya","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib178","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/MEG.0000000000000915","article-title":"Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies","volume":"29","author":"Ortizo","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib179","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/ajg.2016.464","article-title":"Oral contraceptive use and risk of ulcerative colitis progression: a nationwide study","volume":"111","author":"Khalili","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib180","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1572-0241.2007.01700.x","article-title":"Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib181","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cgh.2019.06.042","article-title":"Hormone therapy for cancer is a risk factor for relapse of inflammatory bowel diseases","volume":"18","author":"Axelrad","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib182","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study","volume":"105","author":"Crockett","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib183","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2014.8","article-title":"Isotretinoin and risk of inflammatory bowel disease: a French nationwide study","volume":"109","author":"Racine","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib184","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2013.1344","article-title":"Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data","volume":"149","author":"Etminan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib185","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0000000000000496","article-title":"Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis","volume":"28","author":"Lee","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.04.069_bib186","first-page":"710","article-title":"Colitis associated to chemotherapy with 5-fluorouracil","volume":"44","author":"Trevisani","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2020.04.069_bib187","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1038\/ajg.2009.366","article-title":"Case of fulminant colitis after docetaxel therapy for breast carcinoma in a patient with underlying ulcerative colitis","volume":"104","author":"Lalos","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib188","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/030089160409000219","article-title":"Paclitaxel-carboplatin induced radiation recall colitis","volume":"90","author":"Kundak","year":"2004","journal-title":"Tumori"},{"key":"10.1016\/j.cgh.2020.04.069_bib189","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12664-016-0635-2","article-title":"Colitis induced by sodium polystyrene sulfonate in sorbitol: a report of six cases","volume":"35","author":"Jacob","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.04.069_bib190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/gastro\/gou011","article-title":"Kayexalate-induced colonic ulcer","volume":"2","author":"Albeldawi","year":"2014","journal-title":"Gastroenterol Rep (Oxf)"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520306145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520306145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:35:18Z","timestamp":1761543318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356520306145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":190,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1542356520306145"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.069","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Induced Colitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.04.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}